根据北交所最新披露的信息，2025年12月26日，普昂（杭州）医疗科技股份有限公司IPO的状态从已问 询变更为通过。 根据北交所最新披露的信息，2025年12月26日，普昂（杭州）医疗科技股份有限公司IPO的状态从已问 询变更为通过。 ...

Core Insights - The event aimed to enhance the integration of technology and finance, specifically targeting the financing needs of tech enterprises in Hongqiao District [1] - The successful organization of the financing demand matching meeting is a practical implementation of the city's and district's technology innovation work linkage mechanism [3] Group 1: Event Overview - A financing demand matching meeting titled "Smart Office to Assist Enterprises in Digital Transformation" was held in Hongqiao District, focusing on the financing pain points and development needs of local tech enterprises [1] - Key tech enterprises such as Shunbo Medical and Gongda Galvanization presented their current development status and financing needs during the meeting [3] Group 2: Financial Support - Multiple financial service institutions, including Tianjin OTC and Bozheng Capital, provided tailored capital support solutions across various dimensions such as equity financing, debt support, and industrial chain finance [3] - China Telecom's Tianyi Cloud shared solutions for digital transformation challenges, including smart office and cloud services, to support enterprises in their digital upgrades [3] Group 3: Future Initiatives - The Hongqiao District Science and Technology Bureau plans to innovate service models, enrich matching content, and increase the frequency of activities to strengthen communication and collaboration between tech enterprises and financial institutions [3] - The meeting also facilitated in-depth discussions on topics such as party building, park investment attraction, regional technology achievement transformation, and high-quality enterprise development [3]

Core Viewpoint - Yidu Technology has been invited to participate in the Henan Health Industry Development Conference and has signed on as one of the first partners of the National Artificial Intelligence Application Pilot Base (Medical Direction), marking a strategic expansion in the AI healthcare sector [1][3]. Group 1: Strategic Partnerships and Initiatives - The establishment of the National AI Application Pilot Base in Zhengzhou is a key initiative for Henan Province to implement national health strategies and develop the future health industry [3]. - Yidu Technology is collaborating with major tech companies like Baidu and Alibaba, as well as local medical institutions, to create a synergistic ecosystem that integrates technology, data, clinical applications, and AI in healthcare [3][4]. Group 2: Technological Capabilities and Innovations - Yidu Technology's proprietary "AI Medical Brain" YiduCore has processed nearly 7 billion authorized medical records, covering over 10,000 hospital partnerships, providing a solid foundation for AI model training and clinical insights [5]. - The company aims to leverage its experience in AI and data governance to support the integration of AI with traditional Chinese medicine, enhancing the quality of healthcare services in the region [4][5]. Group 3: Future Development and Goals - Yidu Technology plans to continue its focus on independent innovation and align its AI research and implementation with regional development needs, contributing to the "Healthy China 2030" initiative [5].

南方财经 21世纪经济报道记者胡慧茵 马来西亚槟城报道 在深厚的历史渊源下，多年来，槟城与广东在经贸、文化交往等多领域始终保持着紧密的联系，而近年来双方的投资合作更呈 现双向奔赴的态势。比如，今年10月，广东和槟城共8个单位在投资推介会上签署了多项备忘录与合作协议，进一步促进两地在 商贸与投资领域的交流与合作关系。 近日，马来西亚槟城州首席部长曹观友在接受21世纪经济报道记者专访时表示，槟城与广东的产业有非常明显的互补性，广东 创新能力强，在芯片设计、工业互联网、人工智能、新能源、生物医药及数字经济等领域发展迅速，而槟城在半导体封测、工 业自动化、精密工程、医疗器械制造和高端电子制造方面积累深厚，"这种'设计强 + 制造强'的组合，为双方共同推动跨区域产 业链布局提供强劲动力。" 近年来，马来西亚槟城也成了中企"出海"热潮的目的地。今年10月底，中国企业联特科技二期工厂在槟城开幕，成为中企扎根 当地的典型案例。"从2021年至今，槟城共获得78项来自中国的制造业投资，总额达到168亿林吉特，这反映中国企业对槟城产 业环境与增长潜力的高度认可。"曹观友进一步表示，未来中马有望在人工智能芯片、新能源电池、储能系统 ...

经营范围含一般经营项目是：医院管理；健康咨询服务（不含诊疗服务）；技术服务、技术开发、技术 咨询、技术交流、技术转让、技术推广；第二类医疗器械销售；第一类医疗器械销售；眼镜销售（不含 隐形眼镜）；软件销售；食品销售（仅销售预包装食品）；保健食品（预包装）销售；会议及展览服务 （出国办展须经相关部门审批）；信息技术咨询服务；互联网销售（除销售需要许可的商品）。（除依 法须经批准的项目外，凭营业执照依法自主开展经营活动），许可经营项目是：第三类医疗器械经营； 第三类医疗器械生产；第二类医疗器械生产；生活美容服务；药品零售；互联网新闻信息服务；药品互 联网信息服务；食品销售。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项 目以相关部门批准文件或许可证件为准） 企业名称深圳爱目医疗科技有限公司法定代表人朱奕冰注册资本5000万人民币国标行业卫生和社会工作 >卫生>医院地址深圳市南山区粤海街道科技园社区科苑路16号东方科技大厦1895企业类型有限责任公 司(法人独资)营业期限2025-12-25至无固定期限 来源：市场资讯 天眼查显示，近日，深圳爱目医疗科技有限公司成立，法定代表人为朱奕冰，注册资本 ...

Core Insights - The article highlights the vibrant innovation and entrepreneurial spirit in Shenyang, where local entrepreneurs are actively working on technological breakthroughs and product developments for the future [3][8]. Group 1: Company Innovations - Shenyang Jinran Technology Co., led by CEO Ran Jinchuan, has developed a "MR Science Experiment Course System" that transforms classroom experiences in multiple schools across Liaoning, making dangerous experiments safe and abstract theories visual [4][6]. - Liaoning Ruiyi Technology, founded by Qiu Zhaowen, focuses on using artificial intelligence for early screening and treatment of cardiovascular diseases, aiming to become a "super assistant" for doctors, especially in resource-scarce areas [6][7]. Group 2: Educational Integration - Dong Yingnan, a vice professor at Shenyang Engineering College, emphasizes the importance of "industry-education integration," where students participate in real-world projects, enhancing their practical skills [5][6]. - The collaboration between local universities and companies is seen as a way to cultivate talent that understands both theoretical principles and practical applications, contributing to the city's industrial upgrade [6][7]. Group 3: Future Aspirations - The entrepreneurs express a strong desire to expand their innovations beyond Shenyang, with goals such as national distribution of their products and deeper collaborations with local hospitals [4][6][7]. - The article concludes that the entrepreneurial efforts in Shenyang are not just about individual success but are part of a larger narrative of the city's industrial and technological evolution [7][8].

中新网北京12月25日电(记者 赵方园)"一切医学研究，出发点是病人、源于临床，最后回到生态体系， 在这三个层次上继续形成反哺，这就是我们的发展思路。"近日，在第二届海医汇医疗科技创新生态大 会上，中国工程院院士、中国医学科学院血液病医院(中国医学科学院血液学研究所)院长程涛表示，医 疗行业、大健康产业的成功离不开"政、产、学、研、用"组成的组合拳。 良好的平台与高质量的数据是医疗科技创新的两大基石。中国工程院院士、中国医学科学院血液病医院 (血液学研究所)院长程涛指出，一个优越的创新平台与氛围，能极大释放科研人员的独特思想与研发能 力。 中国医学科学院医学信息研究所所长刘辉提出，让医疗数据"流得通、用得好"需从三方面着力：一是推 进数据标准化与质量治理，实现跨机构、跨模态数据的语义对齐；二是建立全流程可控、技术保障的数 据流通机制，在保障安全与权属前提下释放价值；三是将数据深度融入医学知识体系，构建面向AI应 用的高可信度数据基座。 大会聚焦了由临床迫切需求驱动的尖端科技探索。国家神经疾病医学中心主任、首都医科大学宣武医院 院长赵国光从临床视角深入剖析了脑机接口技术。他指出，针对渐冻症、脊髓损伤等难治性神经 ...

瑞财经 刘治颖 近日，上海英捷信医疗科技有限公司（以下简称"英捷信医疗"）已成功完成数千万元人 民币A+轮融资，本轮融资由毅达资本独家投资，浩悦资本担任独家财务顾问。本轮资金将用于进一步 扩大全球高质量标准的产能体系建设，拓展全球营销与注册团队。 英捷信医疗成立于2021年9月，系一家致力于自我给药系统研发及制造的医疗科技企业。公司目前在售 产品为多款适配胰岛素、GLP-1、生长激素、促卵泡素等生物制剂的高精度笔式注射装置。 天眼查显示，英捷信医疗实际控制人为吴亚金，总持股比例为22.03%，表决权为24.64%。目前，吴亚 金担任公司董事长。 公司总部位于上海，并在江苏无锡设有超10000平米产业化工厂，配套有十万级净化组装车间以及密闭 组装车间。同时公司拥有独立模具加工工厂及零部件注塑工厂，可实现皮下给药装置从设计开发、模具 加工、注塑成型到产品规模化组装的一体化、全流程配套生产服务。截。 ...

Core Viewpoint - Shanghai Ingezhixin Medical Technology Co., Ltd. has successfully completed a multi-million RMB A+ round financing, which will be used to expand its global high-quality production capacity and marketing teams [1] Group 1: Financing Details - The A+ round financing was exclusively invested by Yida Capital, with Haoyue Capital serving as the exclusive financial advisor [1] - The funds raised will support the construction of a global high-quality standard production capacity system [1] Group 2: Company Profile - Ingezhixin Medical is recognized as a national high-tech enterprise focused on independent innovation [1] - The company has established a complete independent intellectual property system through precision manufacturing processes [1] Group 3: Market Position and Products - The company currently provides services to dozens of large domestic and international biopharmaceutical companies [1] - Its product offerings cover multiple fields, including GLP-1 drugs, insulin, and growth hormones, with a leading customer coverage in the domestic GLP-1 sector [1] - Ingezhixin Medical has successfully expanded into multiple overseas markets, demonstrating significant global layout effects [1]

Core Insights - The strategic cooperation between Shandong University Dental Hospital and Weining Health Technology Group marks a significant step towards the integration of quality medical resources and advanced digital technology, contributing to the development of a "digital pioneer city" in Jinan [2][3] - The collaboration aims to enhance the digital transformation of the hospital, focusing on the application of AI in dentistry and the overall digitalization of healthcare services in Shandong Province [2][3] Group 1 - The signing ceremony was attended by key figures including the Chief Engineer of Jinan Big Data Bureau and senior executives from both organizations, highlighting the importance of this partnership [2] - The cooperation is seen as a response to national strategies for digital economic development, aiming to improve healthcare services through technological innovation [3] - The partnership will leverage the multidisciplinary strengths of Shandong University in areas such as artificial intelligence, big data, and IoT to provide robust technical support and innovative solutions [2][3] Group 2 - The Vice President of the hospital and the General Manager of Weining Health's Shandong region signed the strategic cooperation memorandum, indicating formal commitment to the project [4] - Detailed discussions were held regarding the implementation requirements for the smart hospital project, including innovative applications in dentistry and the integration of AI capabilities [4] - Both parties reached a preliminary consensus on future collaboration areas, focusing on specialized applications in dentistry and medical big data [4]